Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Intranasal Cocaine HCl in Healthy Subjects
NCT02667106Phase 1Completed
- Sponsor
- Pharmaceutical Project Solutions
- Start
- Oct 2015
- Primary completion
- Oct 2015
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
01
Overview
Phase 1, open-label, single-arm trial of cocaine in procedural pain, sponsored by Pharmaceutical Project Solutions. Primary endpoint: Pharmacokinetic Measurement of RX0041 at 24 Hours. Started Oct 2015; status: completed.
02
Drugs
cocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02667106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667106.